Filter
2795
Filtered Results: 2795
Text search:
monitoring
of
adverse
effects
Featured
Recommendations
323
New Publications
765
Language
Document type
No document type
1572
Guidelines
479
Studies & Reports
410
Manuals
151
Strategic & Response Plan
95
Training Material
33
Fact sheets
32
Situation Updates
15
Resource Platforms
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
142
Global
112
Kenya
69
Western and Central Europe
62
Ethiopia
61
South Africa
61
Nepal
54
Nigeria
49
Africa
48
Uganda
46
Ghana
41
Tanzania
40
Latin America and the Carribbean
39
Sierra Leone
35
Zambia
35
Malawi
33
Myanmar / Burma
33
Liberia
30
Bangladesh
30
Philippines
25
Rwanda
23
Ukraine
21
Zimbabwe
20
South–East Asia Region
19
Syria
17
Namibia
17
East and Southern Africa
17
Eastern Europe
17
Cambodia
16
Indonesia
13
Guinea
12
West and Central Africa
12
USA
11
South Sudan
11
Botswana
11
Lesotho
11
Middle East and North Africa
11
Senegal
10
Germany
10
Mozambique
10
Eswatini/ Swaziland
10
Eastern Europe and Central Asia
10
Asia
10
Congo, Democratic Republic of
8
Sudan
8
Western Pacific Region
8
Brazil
7
Thailand
6
Russia
6
Moldova
6
Burkina Faso
5
Pakistan
5
Lebanon
5
Yemen
5
Venezuela
5
Mali
4
Somalia
4
Afghanistan
4
Laos
4
Cameroon
3
Niger
3
Haiti
3
Jordan
3
Colombia
3
Ecuador
3
Bhutan
3
Timor Leste/ East Timor
3
Tajikistan
3
Vietnam
3
Iraq
2
Egypt
2
Gambia
2
China
2
Singapore
2
Benin
2
Central African Republic
2
Argentina
2
Angola
2
Madagascar
2
Sri Lanka
2
Kyrgyzstan
2
Georgia
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
1
Chad
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Peru
1
North Macedonia
1
Burundi
1
Greece
1
Chile
1
Other region
1
Paraguay
1
Fiji
1
Poland
1
Palestine
1
North Korea
1
Albania
1
Djibouti
1
Canada
1
Romania
1
Lithuania
1
Iran
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
950
Clinical Guidelines
329
Public Health
170
Women & Child Health
169
Key Resources
135
Capacity Building
44
Pharmacy & Technologies
31
Toolboxes
Mental Health
240
COVID-19
211
TB
194
HIV
193
Planetary Health
139
Pharmacy
92
AMR
84
Caregiver
75
Rapid Response
74
NCDs
69
Conflict
65
NTDs
65
Global Health Education
57
Ebola
51
Refugee
46
Disability
43
Natural Hazards
33
Specific Hazards
33
Cholera
14
Zika
14
Polio
13
Health Financing Toolbox
11
Typhoon
2
Social Ethics
1
This document facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities ... the ministries or secretariats of health and other agencies in charge of communicating about new COVID-19 vaccines in the Americas.
Available in English, Spanish and Portuguese
The National Guideline for Neonatal Care and Establishment of Neonatal Care Unit aims to provide health workers with all basics and necessary knowledge and skills to provide appropriate care at the most vulnerable period in a newborn’s life. This ...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components ... health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ explores impacts that the COVID-19 pandemic did have on patient safety in terms of risks and avoidable harm, specifically in terms of diagnostic, treatment and care management related issues as well as highlights the main patterns of these implications within the broader health system context.
To improve the quality of care during labour and childbirth, facilitate effective implementation of the World Health Organization (WHO) recommendat...
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
Master of Science in Pharmaceutical Management Dissertation
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy ... “re-purposed” drugs that have been widely used to treat other infections but are also showing promise in the treatment of DR-TB, including linezolid and clofazimine. This special supplemental guide has been developed for nurses, because it is essential that nurses be provided with material that maximizes their ability to provide optimal support to patients who are receiving new and re-purposed drugs
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case...
The health and socioeconomic crisis triggered by the COVID-19 pandemic has hit the countries of Latin America hard and laid bare the profound inequities about which numerous international, regional and national reports have sounded warnings in recen...
4–15 February 2013
Original text from 2008, updated in 2012. This document marks the beginning of a structured approach to safety assessment of GE foods, which are yet to be approved in our country. It is understood ...
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial...
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden ... communicable and noncommunicable diseases and rapid urbanization. There is also high income inequality among the population.
